QQ客服 官方微博 反馈留言

	Enhancing therapeutic efficacy of the MEK inhibitor, MEK162, by blocking autophagy or inhibiting PI3K/Akt signaling in human lung cancer cells
	Yao, Weilong; Yue, Ping; Zhang, Guojing; Owonikoko, Taofeek K.; Khuri, Fadlo R.; Sun, Shi-Yong*
刊名	Cancer Letters
	2015
卷号	364期号:1页码:70-78
关键词	MEK162 BKM120 Autophagy Lung cancer
ISSN号	0304-3835
DOI	10.1016/j.canlet.2015.04.028
URL标识	查看原文
WOS记录号	WOS:000356112000008
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3322148
专题	中南大学
作者单位	[Yao, Weilong] Cent S Univ, Xiangya Hosp, Dept Respirat, Changsha, Hunan, Peoples R China.
推荐引用方式 GB/T 7714	Yao, Weilong,Yue, Ping,Zhang, Guojing,et al. Enhancing therapeutic efficacy of the MEK inhibitor, MEK162, by blocking autophagy or inhibiting PI3K/Akt signaling in human lung cancer cells[J]. Cancer Letters,2015,364(1):70-78.
APA	Yao, Weilong,Yue, Ping,Zhang, Guojing,Owonikoko, Taofeek K.,Khuri, Fadlo R.,&Sun, Shi-Yong*.(2015).Enhancing therapeutic efficacy of the MEK inhibitor, MEK162, by blocking autophagy or inhibiting PI3K/Akt signaling in human lung cancer cells.Cancer Letters,364(1),70-78.
MLA	Yao, Weilong,et al."Enhancing therapeutic efficacy of the MEK inhibitor, MEK162, by blocking autophagy or inhibiting PI3K/Akt signaling in human lung cancer cells".Cancer Letters 364.1(2015):70-78.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。